Table 1.
Characteristics of patients with Costello syndrome and rhabdomyosarcoma.
| PT number | Author | Year | Country | Sex | Age at diagnosis (years/months) | Symptoms | Location | Histology | Mutation AAC (NS) | Therapy | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kerr et al. [7, 8] | 1998 | England | F | 2 y 4 m | Vomiting Constipation |
Retroperitoneal: left psoas mayor muscle | Embryonal | G12S (34G>A)∗ [9] | S, ChT | Relapse, tumor-free age of 7 years |
| 2 | Kerr et al. [7, 8] | 1998 | England | F | 3 y 2 m | Abdominal mass | Pelvis: urachus (median UL), adherent to the bladder | Embryonal | G12A (35G>C) [5] | S, ChT | Histology showed extending up to the resection margin Died aged 5 years [5, 9] |
| 3 | Feingold [8, 10] | 1999 | USA | M | 6 m | Tumor | Right foot | Alveolar | NDF | S, ChT | Tumor-free age of 20 years [11] |
| 4 | Bisogno et al. [8, 9, 12] | 1999 | Italy | M | 1 y 8 m | Constipation Abdominal pain |
Lower abdomen, pelvis: abdominal wall∗ | Embryonal | NDF | S, ChT | Only biopsy Died aged 2 years and 3 months |
| 5 | Sigaudy et al. [8, 13] | 2000 | France | M | 6 y | NDF | Inguinal/scrotal | Embryonal | NDF | NDF | NDF |
| 6 | Gripp et al. [8, 14, 15] | 2002 | USA | M | 5 y 6 m | Abdominal pain | Pelvis: pulmonary metastases was present | Embryonal | NDF | S, ChT | Died after recurrence [14] |
| 7 | Gripp et al. [8] | 2002 | USA | F | 3 y 7 m | Abdominal pain Emesis |
Upper abdomen: mass encasing the superior mesenteric an celiac arteries. Single pulmonary nodule | Pleomorphic | NDF | ChT | Died aged 4 years |
| 8 | Gripp et al. [8] | 2002 | USA | F | 2 y 6 m | Abdominal mass | Pelvis: bladder | Embryonal | NDF | ChT, RT, S | Died aged 7 years for recurrency of RMS/fibrosarcoma [16] |
| 9 | Gripp et al. [8] | 2002 | USA | NDF | 7 m | Perineal growth | Perineal | Embryonal | NDF | ChT, RT, S | Tumor-free age of 2 years |
| 10 | Gripp et al. [8] | 2002 | USA | NDF | 1 y 11 m | Proptosis | Left orbit | Unknown | NDF | S, RT | Tumor-free age of 4 years |
| 11 | Kawame et al. [17] | 2003 | Japan | F | 1 y 4 m | Abdominal mass | Pelvis | Spindle cell | NDF | S, ChT | Tumor-free age of 7 years |
| 12 | Kerr et al. [18] | 2003 | UK | M | 2 y 2 m | Large pelvic mass | Retrovesicular mass by ultrasound | Embryonal | NDF | ChT | Died aged 2 years and 4 months |
| 13 | O'Neal et al. [19] | 2004 | USA | F | 3 y | Right-sided cervicofacial mass | Parameningeal infratemporal fossa: right periparotid masticator space region | Alveolar | NDF | ChT, S, RT | Clinical group 3 T2b N0 stage 3 Died during surgery |
| 14 | Gripp [20] | 2005 | USA | F | 3 y 2 m | Facial mass | Right infratemporal fossa | Mixed alveolar and embryonal | NDF | ChT, S | Died during surgery by ventricular tachycardia followed rapidly by loss of heart rhythm |
| 15 | Aoki et al. [21, 22] | 2005 | Japan | F | 7 y 2 m | NDF | NDF | NDF | G12S (34G>A) | NDF | NDF |
| 16 | Gripp et al. [9] | 2006 | USA | M | 2 y | NDF | NDF | NDF | G12S (34G>A) | NDF | Tumor-free age of 11 years∗ |
| 17 | Kerr et al. [5] | 2006 | UK | NDF | 7 m | NDF | Metastatic arising from the prostate | Embryonal [23] | G12C (34G>T) | NDF | Died aged 7 months |
| 18 | Kerr et al. [5] | 2006 | UK | NDF | NDF | NDF | NDF | NDF | G12S (34G>A) | NDF | Died aged 7 years |
| 19 | Kerr et al. [5] | 2006 | UK | NDF | NDF | NDF | NDF | NDF | G12A (35G>C) | NDF | NDF |
| 20 | Lo et al. [23] | 2008 | UK | M | 2 y 3 m | Respiratory function deteriorated | Right lung | NDF | G12S (34G>A) | S | Died few weeks later surgery |
| 21 | Ahmadi and Harley [6] | 2010 | USA | M | 2 y | Increased work of breathing | Nasopharyngeal | Embryonal | NDF | S, ChT, RT | Clinical group IIA (T1N0M0) Tumor-free age of 3 years |
| 22 | Abe et al. [22] | 2012 | Japan | NDF | NDF | NDF | NDF | NDF | NDF | NDF | Died |
| 23 | Menke et al. [24, 25] | 2015 | Germany | F | 3 y | Abdominal mass | Lower anterior abdomen, above the urinary bladder∗ (urachus-median UL by location) | Embryonal | G12C (34G>T) | S, ChT | R1 resection (marginal tumor residue). Tumor-free age of 6 years |
| 24 | Kratz et al. [25] | 2015 | Germany | M | 1 y | NDF | NDF | Embryonal | G12S (34G>A) | NDF | NDF |
| 25 | Sánchez-Montenegro et al. (this report) | 2017 | Spain | F | 2 y 4 m | Asymptomatic | Left medial UL | Embryonal | G12A (35G>C) | ChT, S, RT | Tumor-free age of 4 years and 4 months |
| 26 | Sánchez-Montenegro et al. (this report) | 2017 | Spain | F | 3 y 10 m | Asymptomatic | Right medial UL | Spindle cell | G12S (34G>A) | S, ChT | Tumor-free age of 5 years and 4 months |
AAC, amino acid change; ChT, chemotherapy; F, female; M, male; NDF, no data found; NS, nucleotide substitution; PT, patient; RT, radiotherapy; S, surgery; UL, umbilical ligament. ∗Personal communication by author.